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Background and aims: Pathological gambling (PG) is an impulse control disorder. This study assessed the burden of
co-occurring behavioral addictions and mental health disorders in treatment-seeking patients and estimated the
likelihood of receiving care for these disorders by clinician specialty. Methods: Study data were derived from the
Massachusetts All-Payer Claims Database, a representative database, for the period 2009–2013. The sample included
commercially insured adult residents of Massachusetts. Univariate and multivariate logistic regressions were used to
estimate the likelihood of provision of care by clinician specialty adjusting for patient’s demographic characteristics
and level of care. Bonferroni correction was applied to adjust for multiple testing. Results: The study sample included
869 patients. Treatment-seeking patients who had a diagnosis of PG were mostly males (71%), aged 45–54 years
(26.7%) and enrolled in a health maintenance organization (47%). The most prevalent co-occurring disorders among
patients with PG as principal diagnosis were anxiety disorders (28%), mood disorders (26%), and substance use
disorders (18%). PG was associated with a more than twofold likelihood of receiving care from social workers and
psychologists (p< .05). Depressive disorders were associated with a three times greater likelihood of receiving care
from primary care physicians (PCPs) (p< .05). Having three and four or more diagnosis was associated with a greater
likelihood of receiving care from PCPs. Discussion and conclusions: Psychiatric and substance use disorders are
prevalent among treatment-seeking pathological gamblers. The likelihood of receiving care from specialty clinicians
signiﬁcantly varies by clinical diagnosis and patient clinical complexity.
Keywords: behavioral addictions, mental health disorders, treatment provision, clinician specialty, pathological
gambling, All-Payer Claims Data
INTRODUCTION
Pathological gambling (PG) is an impulse control disorder
characterized by a persistent and recurrent maladaptive
behavior that disrupts personal, family, or vocational pur-
suits (American Psychiatric Association, 2000). In the
United States (US), the lifetime prevalence rate of PG in
the adult population ranges from 0.42% to 1.9% (Petry,
Stinson, & Grant, 2005; Welte, Barnes, Wieczorek, Tidwell,
& Parker, 2002).
PG is known to be associated with other psychiatric
disorders (Dowling, Merkouris, & Lorains, 2016; Grant,
Levine, Kim, & Potenza, 2005; Lorains, Cowlishaw, &
Thomas, 2011; Suomi, Dowling, & Jackson, 2014). Mood
disorders, including bipolar disorders and major depressive
affective disorders, personality disorders and anxiety dis-
orders are most often comorbid with PG (Chou & Aﬁﬁ,
2011; Kim, Grant, Eckert, Faris, & Hartman, 2006). Sub-
stance use disorders are also concurrent with PG (Lorains
et al., 2011; Petry et al., 2005). Alcohol abuse and depen-
dence (Chou & Aﬁﬁ, 2011; Suomi et al., 2014), tobacco
dependence (Boothby, Kim, Romanow, Hodgins, &
McGrath, 2017), and drug abuse (Johansson, Grant, Kim,
Odlaug, & Götestam, 2009) are highly prevalent among
pathological gamblers. A literature review of population-
based surveys found that the highest mean prevalence for
combined samples of problem and PG was for nicotine
dependence (60.1%), followed by a substance use disorder
(57.5%), alcohol use disorder (28.1%), and illicit drug
abuse/dependence (17.2%). For mental health disorders, the
highest mean prevalence was for any type of mood disorder
(37.9%), any type of anxiety disorder (37.4%), and major
depression (23.1%) (Lorains et al., 2011).
Prior studies have suggested that psychiatric disorders
and alcohol and drug dependence and other non-dependent
abuse of drugs typically predate the onset of disordered
gambling (Kessler et al., 2008). Conversely, there is also
evidence that disordered gambling precedes and predicts the
onset of other mental health conditions, such as bipolar
disorders, generalized anxiety disorders, and post-traumatic
stress disorders (Chou & Aﬁﬁ, 2011; Pilver, Libby, Hoff, &
Potenza, 2013). Research has also suggested that disordered
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gambling is a risk factor for the development of alcohol,
nicotine, and cannabis dependence and illicit drug use
(Chou & Aﬁﬁ, 2011; Pilver et al., 2013).
In 2011, Massachusetts (MA) enacted the Expanded
Gaming Act legalizing commercial casino gambling. Scar-
city of studies on treatment-seeking behaviors among
pathological gamblers and associated treatment provision
along with recent legislation provides the impetus to
this study. This study assessed the sociodemographic
characteristics of patients seeking treatment for PG and
co-occurring substance use-related addictions and mental
health disorders, analyzed the workforce composition and
geographic distribution of treatment providers, and esti-
mated the likelihood of patients receiving care by clinician
specialty.
To the authors’ knowledge, this is the ﬁrst study to
assess the prevalence of co-occurring addictive behaviors
and mental health disorders in pathological gamblers
seeking treatment across all levels of care during a
comprehensive period of time before casinos become
operative in MA in 2018. Thus, this study has the
potential to make a signiﬁcant intellectual contribution
to understanding the burden of psychiatric disorders and
behavioral addictions and to inform clinicians’ workforce
composition and future study projections to address
patients’ treatment provision.
METHODS
The Massachusetts All-Payer Claims Database (APCD) is a
representative health claims database from public and pri-
vate payers in MA. Study data were derived from all
medical and pharmaceutical claims for MA residents cov-
ered by the 16 largest private commercial payers in MA with
dates of service from January 1, 2009 through June 30,
2013. Study data included patient demographics (i.e., age,
gender, and zip code), type of health insurance coverage
(i.e., private and public insurance) and commercial insur-
ance plan [i.e., health maintenance organization (HMO),
preferred provider organization, point of service, and
indemnity insurance], International Statistical Classiﬁca-
tion of Diseases and Related Health Problems codes
(i.e., ICD-9-CM codes), health-care services and pharma-
ceuticals provided in all health-care settings in MA, service
dates, provider zip code, and clinician specialty. Health-
care services included physician/outpatient visits, inpatient
and emergency department visits, and prescription drugs.
Participants
Patients with a diagnosis of PG ascertained by ICD-9-CM
code “31231” any time in the study period were included in
the study. Co-occurring mental health and substance
use disorders were classiﬁed into episodic mood
disorders (ICD9-296) and neurotic personality disorders
(ICD9-300–316). Neurotic personality disorders were clas-
siﬁed as anxiety disorders (ICD9-300), adjustment reaction
(ICD9-309) and depressive disorders (ICD9-311), disorders
of impulsive control (ICD9-312), and psychoactive sub-
stance disorders (ICD9-303–305). Psychoactive substance
disorders were broken down into alcohol dependence
syndrome (ICD9-303), drug dependence (ICD9-304), and
non-dependent abuse of drugs (ICD9-305). Non-dependent
abuse of drugs included alcohol abuse (ICD9-305.0),
tobacco use disorder (ICD9-305.1), cannabis abuse (ICD9-
305.2), opioids abuse (ICD9-305.5), and cocaine abuse
(ICD9-305.6).
Measures
We created categorical variables for co-occurring disor-
ders to estimate the likelihood of receiving care by
assessed clinician specialties associated with each diag-
nosis with respect to all other mental health and psy-
choactive substance diagnosis and with the number of
prevalent co-occurring disorders as a bundle (i.e., one,
two, three, and four or more diagnosis). Prevalence rates
were reported as the percentage of patients with each
speciﬁc co-occurring disorder divided by total number of
patients with a diagnosis of PG, either as a principal or
primary diagnosis in a given year.
Patients were excluded from the analytical sample if they
were under the age of 18 years (n= 13 patients over the
study period), lived in a zip code outside MA (n= 8) or
received care from a provider in a zip code outside MA
(n= 2) anytime during the study period. In addition, patients
who only had public insurance coverage in all their claims
(n= 62 patients over the study period) were excluded from
the analysis. Patients who switched from public to private
insurance or vice versa in a given year (n= 1) were kept in
the analytical sample. Patients whose ﬁrst claim appeared in
the period of January–June 2013 (n= 27) were excluded
from the analysis so as to have a minimum of 6-month time
span for claims data processing.
Analysis of the provision of health-care services included
all levels of care in all health-care settings across the
Commonwealth of Massachusetts. Analysis of the likeli-
hood of receiving care for mental health and substance use
disorders by clinician specialty included therapeutic provi-
ders (e.g., counseling psychologists and clinical social
workers) and prescribing providers (e.g., psychiatrists and
general practice physicians). Analysis of the geographic
distribution of providers and patients was performed by
Massachusetts County.
Statistical analysis
Descriptive statistics were performed for main study vari-
ables by year and overall for the entire study period.
Univariate and multivariate analyses, prevalence estimates,
and 95% conﬁdence intervals were performed to examine
patient sociodemographic characteristics and prevalence of
PG and co-occurring disorders. Multivariate logistic regres-
sion was conducted to estimate the likelihood of receiving
care by assessed clinician specialties holding constant socio-
demographic variables, type of health insurance coverage,
and level of care. The following equation represents the
model:
PrðY i = 1 jX 1i, X 2iÞ=Fðβ0 + β1X 1i + β2X 2iÞ + ui,
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where i= 1, : : : , n individuals, ui the error term – errors are
independent and identically distributed, N(0, σ2ν) – and F is
the standard normal cumulative distribution function. Y
represents the provider specialty, X1 represents a vector of
patient’s sociodemographic characteristics, X2 represents
type of health insurance coverage (i.e., HMO vs. other type
of insurance), and X3 represents level of care. Odds ratio
estimates indicate the probability of the outcome variable
associated with the assessed explanatory variables. Bon-
ferroni correction was applied to adjust for multiple testing.
All study analyses were performed using STATA MP
Software, version 14.0 (StataCorp 2014, Stat Statistical
Software, Release 14, StataCorp LLC, College Station,
TX, USA) and SAS 9.1 (SAS Institute Inc.,
Cary, NC, USA).
Ethics
This study used de-identiﬁed administrative claims data.
The Massachusetts Department of Public Health and the
UMass Institutional Review Board granted study
approval.
RESULTS
The study analytical sample included 869 MA residents
with a clinical diagnosis of PG who sought care in the
Commonwealth at some time during the study period.
Overall, treatment-seeking patients who had a diagnosis of
PG and co-occurring disorders were mostly males (71%),
aged 45–54 years (26.7%), living in the Middlesex County
(25%), and enrolled in a HMO (47%) (Table 1).
In the period from January 1, 2009 through December 31,
2012, 447 (51.4%) and 373 (42.9%) of treatment-seeking
patients had PG as a principal and primary diagnosis,
respectively. The most prevalent primary diagnoses, in
patients who had PG as a principal diagnosis, were anxiety,
dissociative and somatoform disorders (27.8%), episodic
mood disorders (25.6%), and depressive disorders (13.3%)
(Table 2). Adjustment reaction prevalence (9.4%) included
adjustment disorder with predominant disturbance of other
emotions and post-traumatic stress disorders. Prevalence of
disorders of impulse control, not elsewhere classiﬁed (9%)
included unspeciﬁed impulse control disorders and PG.
Psychoactive substance disorders (17.8%) including alcohol
Table 1. Sociodemographic characteristics of treatment-seeking patients
2009 2010 2011 2012 2009–2012
Age
18–24 11 2.7% 21 4.3% 22 4.8% 18 4.2% 36 4%
25–34 52 12.8% 59 12.0% 58 12.7% 45 10.5% 118 14%
35–44 95 23.3% 108 22.0% 94 20.6% 95 22.2% 199 23%
45–54 126 31.0% 145 29.5% 129 28.2% 124 29.0% 249 29%
55–64 101 24.8% 126 25.6% 121 26.5% 109 25.5% 202 23%
65+ 22 5.4% 33 6.7% 33 7.2% 37 8.6% 65 7%
Gender
Female 122 30.0% 131 26.6% 133 29.1% 127 29.7% 252 29%
Male 285 70.0% 361 73.4% 324 70.9% 301 70.3% 617 71%
Commercial insurance plan
Health maintenance organization (HMO) 197 56.6% 250 60% 224 58% 202 57% 321 47%
Preferred provider organization 103 29.6% 119 28% 104 27% 94 26% 245 36%
Point of service 32 9.2% 36 9% 36 9% 34 10% 85 13%
Exclusive provider organization 14 4.0% 15 4% 14 4% 17 5% 29 4%
Indemnity insurance 5 1.4% 10 2% 18 5% 17 5% 27 4%
Total patients with private health insurance 348 86% 419 85% 386 84% 355 83% 678 78%
Patients by county
Barnstable 6 1% 9 2% 9 2% 7 2% 13 1%
Berkshire a a 10 2% 9 2% 11 3% 13 1%
Bristol 52 13% 63 13% 62 13% 53 12% 109 12%
Essex 41 10% 38 8% 43 9% 39 9% 88 10%
Franklin 8 2% 7 1% 8 2% a a 10 1%
Hampden 25 6% 38 8% 36 8% 28 6% 63 7%
Hampshire 11 3% 14 3% 10 2% 15 3% 23 3%
Middlesex 99 24% 130 26% 109 23% 105 24% 226 25%
Norfolk 60 14% 70 14% 53 11% 55 13% 122 14%
Plymouth 34 8% 32 6% 40 9% 45 10% 76 8%
Suffolk 35 8% 39 8% 37 8% 36 8% 66 7%
Worcester 40 10% 52 10% 51 11% 40 9% 87 10%
Total patients by county 414 502 467 438 897
Total patients by analytical sample 407 492 457 428 869
Note. A patient may be in more than one county within a 1-year time period.
aSuppressed data.
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dependence (8.3%), drug dependence (i.e., opioid-, anxio-
lytic-, cocaine-, and cannabis dependence) (4.4%), and non-
dependent abuse of drugs (i.e., alcohol abuse, tobacco use
disorders, and cannabis-, opioid-, and cocaine abuse) (5.0%)
were also prevalent conditions among patients with PG as a
principal diagnosis (Figure 1).
The most prevalent principal diagnoses, in patients who
had PG as a primary diagnosis, were episodic mood
disorders (34.7%), anxiety, dissociative and somatoform
disorders (17%), and depressive disorders (7.5%) (Table 3).
Psychoactive substance disorders (9.3%) including alcohol
dependence (3.5%), drug dependence (5.9%), and non-
dependent abuse of drugs (2.0%) were also prevalent prin-
cipal diagnoses among patients with PG as a primary
diagnosis (Figure 1). In the study period, PG was the
hospital admitting diagnosis for 3%–5% of the treatment-
seeking patients in the analytical sample.
The geographic location of treatment-seeking patients
with a diagnosis of PG who received care across settings in
the Commonwealth and their health-care provider practice
ofﬁces/settings were not evenly distributed (Figure 2). Prev-
alence of PG and concurrent psychiatric and substance use
disorders were higher than the county population in
Middlesex (25% and 23%, respectively), Norfolk (14% and
10%, respectively), and Bristol Counties (12% and 8%,
respectively) (U.S. Census Bureau, 2010). In addition, the
percentage of treatment-seeking patients with a diagnosis of
PG and concurrent disorders was greater than the percentage
of assessed clinicians providing treatment services in Mid-
dlesex (25% and 21%, respectively) and Norfolk (14% and
12%, respectively) Counties. Conversely, 7% of patients
lived in the Suffolk County where 13% of the clinicians
provided care.
Adjusting for patient’s demographic characteristics, type
of health insurance plan and level of care, the likelihood of
receiving care by specialty of clinicians signiﬁcantly varied
by patient’s diagnosis and number of co-occurring disorders.
PG as a principal diagnosis was associated with almost a three
times greater probability of receiving care from psychologists
(2.8, p< .01) and social workers (2.6, p< .01) and a lower
Table 2. Prevalence rates for primary diagnosis among patients with pathological gambling as principal diagnosis, ICD-9-CM codes
2009 2010 2011 2012 2009–2012
Episodic mood disorders (296) 19 25.7% 23 23.2% 21 22.1% 16 18.8% 46 25.6%
Neurotic disorders, personality disorders, and other non-psychotic mental disorders (300–316)
Anxiety, dissociative, and somatoform disorders
(300.0–300.9)
20 27.0% 26 26.3% 27 28.4% 22 25.9% 50 27.8%
Psychoactive substance (303–305) 15 20.3% 17 17.2% 15 15.8% 14 16.5% 32 17.8%
Adjustment reaction (309.0–309.9) 9 12.2% 7 7.1% 9 9.5% 7 8.2% 17 9.4%
Depressive disorder, not elsewhere classiﬁed (311) 12 16.2% 13 13.1% 13 13.7% 10 11.8% 24 13.3%
Disorders of impulse control, not elsewhere
classiﬁed (312.3)
7 9.5% 6 6.1% 8 8.4% 9 10.6% 17 9.4%
Patients with principal diagnosis when PG is
principal diagnosis
204 50.1% 247 50.2% 229 50.1% 204 47.7% 447 51.4%
Patients with ﬁrst diagnosis when PG is principal
diagnosis
74 36.3% 99 40.1% 95 41.5% 85 41.7% 180 40.3%
8%
5%
4%
4%
2%
6%
0%
5%
10%
Alcohol dependence
syndrome
Non-dependent abuse of
drugs
Drug dependence
Figure 1. Most prevalent psychoactive substance diagnosis among treatment-seeking patients, 2009–2012. Note. Non-dependent abuse of
drugs includes alcohol abuse, tobacco use disorder, cannabis abuse, opioid abuse, and cocaine abuse. Drug dependence includes opioid-type
dependence and anxiolytic-, cocaine-, and cannabis dependence. Chart includes treatment-seeking patients with primary diagnosis (n= 180)
out of 447 patients who had pathological gambling as principal diagnosis and patients with a principal diagnosis when pathological gambling
was primary diagnosis (n= 373) out of 869 patients in the analytical sample who had a principal diagnosis
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probability of receiving care from primary care physicians
(PCPs) and psychiatrists (0.4; p< .01) (Table 4). Conversely,
compared with other concurrent mental health diagnosis,
depressive disorder diagnosis was associated with greater
than three times likelihood of receiving care from PCPs
(3.5; p< .01).
Furthermore, the likelihood of receiving care by clini-
cian specialty was signiﬁcantly associated with number of
co-occurring psychiatric disorders. Treatment-seeking
patients with three diagnoses had a 2.9 and 4.7 times
greater likelihood of receiving care from PCPs and psy-
chiatrists, respectively (p < .01) and a lower likelihood of
receiving care from psychologists (p < .001) and social
workers (p < .05) compared with treatment-seeking
patients with one clinical diagnosis. Likewise, patients
with four or more co-occurring disorders had almost six
times (p < .001) greater likelihood of receiving care
from a PCP.
DISCUSSION
Despite the wealth of literature on the association between
psychiatric and addictive disorders and gambling disor-
ders (Dowling et al., 2015; Kessler et al., 2008), there
are still very little data about pathological gamblers
seeking treatment (Winters & Kushner, 2003). Prior
research assessed self-reported comorbidity prevalence of
psychiatric disorders in pathological gamblers seeking
treatment in outpatient settings (Ibanez et al., 2001;
Kausch, 2003; Specker, Carlson, Edmonson, Johnson, &
Marcotte, 1996). To the best of our knowledge, this is the
only study that has been conducted using a representative
sample of pathological gamblers seeking treatment across
all levels of care. In addition, this study is the most
comprehensive examination of comorbid psychiatric
and psychoactive substance use disorders among
treatment-seeking pathological gamblers and assessment
Table 3. Prevalence rates for principal diagnosis among patients with pathological gambling as primary diagnosis, ICD-9-CM codes
2009 2010 2011 2012 2009–2012
Episodic mood disorders (296) 77 48.1% 74 38.3% 72 39.1% 78 41.5% 157 42.1%
Neurotic disorders, personality disorders, and other non-psychotic mental disorders (300–316)
Anxiety, dissociative, and somatoform disorders
(300.0–300.9)
28 17.5% 41 21.2% 36 19.6% 40 21.3% 77 20.6%
Psychoactive substance (303–305) 26 16.3% 25 13.0% 25 13.6% 32 17.0% 42 11.3%
Adjustment reaction (309.0–309.9) 10 6.3% 20 10.4% 20 10.9% 46 24.5% 33 8.8%
Depressive disorder, not elsewhere classiﬁed (311) 14 8.8% 16 8.3% 15 8.2% 8 4.3% 34 9.1%
Disorders of impulse control, not elsewhere
classiﬁed (312.3)
9 5.6% 9 4.7% 9 4.9% 10 5.3% 23 6.2%
Patients with principal diagnosis when PG is ﬁrst
diagnosis
179 89.4% 218 88.5% 206 89.3% 213 88.3% 452 82.5%
Patients with PG as ﬁrst diagnosis 160 39.3% 193 39.2% 184 40.3% 188 43.9% 373 42.9%
Note. Non-dependent abuse of drugs (ICD9-305.0–305.9) includes alcohol abuse (ICD9-305.0), tobacco use disorder (ICD9-305.1), cannabis
abuse (ICD9-305.2), opioid abuse (ICD9-305.5), and cocaine abuse (ICD9-305.6). Drug dependence (ICD9-304) includes opioid-type
dependence (ICD9-304.0) and anxiolytic, cocaine, and cannabis dependence (ICD9-304.1–304.9).
Adjustment reaction (ICD9-309.0–309.9) includes adjustment disorder with predominant disturbance of other emotions (ICD9-309.0–309.9)
and post-traumatic stress disorder (ICD9-309.81). Disorders of impulse control, not elsewhere classiﬁed (ICD9-312.3), include impulse
control disorder, unspeciﬁed (ICD9-312.30), and pathological gambling (ICD9-312.31).
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Figure 2. Treatment-seeking patients and health-care providers by Massachusetts County, 2009–2012. Note. Data for Nantucket and Dukes
County were suppressed
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of treatment provision by clinician specialty conducted to
date.
Study results show that anxiety disorders, episodic mood
disorders, depressive disorders, and psychoactive substance
disorders are prevalent co-occurring conditions among path-
ological gamblers seeking treatment for mental health and
substance use disorders. This study found that one in four
treatment-seeking patients with a principal diagnosis of PG
had a concurrent diagnosis of anxiety disorders and mood
disorders. In addition, one in ﬁve patients with a principal
diagnosis of PG had a concurrent diagnosis of substance use
disorders. In a prior study, Ibanez et al. (2001) assessed
frequency of psychiatric comorbidity among a convenient
sample of 69 pathological gamblers who applied to a
specialized outpatient treatment program. A little over two
in ﬁve pathological gamblers self-reported having a concur-
rent personality disorder and one in three self-reported
having an alcohol abuse or dependence disorder (Ibanez
et al., 2001).
Overall, prevalence rates of psychiatric and substance use
disorders found in this study are lower than in previous
studies, which may be related with some important meth-
odological differences. First, this study focused on the most
severe form of disordered gambling (i.e., PG as opposed to
problem gambling). Second, this study included treatment-
seeking patients with a clinical diagnosis of PG based on
ICD-9 codes rather than DSM-IV Axis I disorders. Third,
study ﬁndings have to be interpreted within the context of
the US health-care system. Most previous studies assessing
prevalence of co-occurring conditions among disordered
gamblers seeking treatment were conducted in countries
with universal health insurance coverage where patients
have access to a broad range of publicly funded health-care
services and treatment providers.
In 2015, two thirds of the population in MA had health-
care coverage through private commercial plans and 4 in 10
commercially insured residents were enrolled in an HMO.
HMOs offer a broad range of health-care services through a
closed network of preferred providers and a PCP referral is
required for HMO enrollees to access specialists. In line
with state health insurance ﬁgures, this study found that
almost two thirds of patients seeking care in the Common-
wealth for PG and co-occurring disorders were enrolled in a
HMO. Furthermore, study ﬁndings show that, compared
with any other type of health insurance plan, having health
insurance coverage through an HMO was signiﬁcantly
associated with a three times greater likelihood of receiving
care from a PCP.
Little is known about the workforce composition and
specialty of clinicians providing care for pathological gam-
blers with concurrent mental health and substance use
disorders. Notably, this study found an unbalanced distri-
bution of health-care providers across MA Counties and a
shortage of mental health professionals in counties dispro-
portionally affected by the burden of the disease.
Prior research has suggested that disordered gambling is
common in primary care settings (Cowlishaw, Merkouris,
Chapman, & Radermacher, 2014; Dowling et al., 2014;
Pasternak & Fleming, 1999). Nevertheless, clinicians rarely
screen for gambling disorders and disordered gamblers seek
care for their comorbid conditions rather than their gambling
problems (Drebing et al., 2001; Lorains et al., 2011;
Sullivan, Arroll, Coster, Abbott, & Adams, 2000; Winters
& Kushner, 2003). Kessler et al. (2008) found that almost
half of the respondents with a lifetime PG self-reported
receiving treatment for psychiatric or substance use pro-
blems in their life; whereas, none of them self-reported
receiving treatment for gambling problems. Hence, gam-
bling disorders often remain undiagnosed until psychiatric
and substance use disorders become overt.
This study found that the probability of receiving care
from psychologists, mental health and substance abuse
social workers, psychiatrists, and PCPs was signiﬁcantly
associated with patients’ diagnosis and clinical complexity,
proxied by the number of concurrent disorders. Further-
more, study ﬁndings suggest that treatment-seeking patients
did not seek care from family physicians for their gambling
problems as their main clinical condition but as a bundle
involving multiple disorders and conditions. Hence, study
ﬁndings suggest the important role of primary care practi-
tioners routinely screening for disordered gambling symp-
toms and co-occurring addictive behaviors and holistically
addressing such behaviors. Therefore, strategies raising
awareness among family practitioners may provide a unique
opportunity for surveillance, more effective prevention
interventions and comprehensive health-care treatment
provision.
Finally, study ﬁndings suggest that health-care services
provision and counseling may be fragmented into therapeu-
tic interventions, such as cognitive behavioral therapy,
cognitive therapy, and motivational interventions, typically
provided by psychologists, mental health and substance
abuse social workers, and mental health counselors and
pharmacological treatment typically provided by psychia-
trists and PCPs. While the US Food and Drug Administra-
tion has not approved a prescription drug for gambling
disorders, opioid antagonists, antidepressants, mood stabi-
lizers, and atypical antipsychotics are often prescribed off-
label for disordered gamblers seeking treatment. Given the
prevalence of co-occurrent mental health and substance use
disorders in treatment-seeking patients with diagnosis of
PG, prescribers should carefully assess the risk of prescrip-
tion drug misuse and abuse. Thus, comprehensive and
coordinated behavioral therapy and treatment provision
remains a requisite for cost-effective care.
Limitations
This study has some limitations common in administrative
claims-based studies including coding accuracy and data
completeness. Claims data are dependent on professional
ICD coding. Diagnoses were based on ICD-9-CM codes
recorded in clinical encounters and no chart review was
performed. We could not determine whether the medical
encounter was for a new or established patient. There is also
the possibility of residual confounding due to variables not
included in the claims database. For example, payers typi-
cally do not capture race and ethnicity information that may
inﬂuence treatment-seeking behaviors.
This study focused on psychiatrists, non-psychiatrists,
mental health and substance use specialists (i.e.,
psychologists and social workers), and primary care doctors.
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Efforts were made to identify provider specialty classiﬁed as
unknown. Provider entity codes and level of care data
elements were reviewed as needed. When determination of
provider specialty was not possible, the provider specialty
was classiﬁed as unknown. No imputation approaches were
performed.
In 2015, 61% of MA residents had a commercial insur-
ance plan through an employer [Center for Health Informa-
tion and Analysis (CHIA), 2016]. In addition, 16% and 19%
of MA residents received their health insurance coverage
through Medicare and Medicaid (i.e., MassHealth), respec-
tively. The MA APCD includes residents with primary
health-care coverage through the top 16 commercial payers
in the Commonwealth. In 2013, the MA APCD medical and
pharmaceutical claims data represented 89.5% and 83.8% of
health-care expenditures, respectively (CHIA, 2016). This
study focused on the commercially insured population
seeking care in MA. This limits the generalizability of study
ﬁndings to uninsured or non-commercially insured popula-
tions or other jurisdictions.
Study results show that PG is comorbid with mental
health and substance use disorders. The cross-sectional
nature of this study precludes a temporal association
between these disorders. It may be that some mental health
and substance use disorders are risk factors for PG; where-
as, others might be a consequence of a PG disorder.
Similarly, we cannot unequivocally determine whether
patients sought care for their gambling problems or the
underlying co-occurring mental health and substance use
disorders. In spite of these limitations, administrative
claims data are real-world valuable and a relatively inex-
pensive data source.
CONCLUSIONS
Study results show both the clinical complexity and the
wide range of comorbid psychiatric and behavioral addic-
tions among pathological gamblers seeking treatment and
suggest the need for a more integrated and comprehensive
provision of care. The likelihood of receiving care for PG
and co-occurrent psychiatric and substance use disorders
signiﬁcantly varies by clinical diagnosis and number of
comorbid conditions. Mental health and substance use
providers may play a key role in identifying and addressing
disordered gambling and co-occurring addictive behaviors.
Study ﬁndings have the potential to illuminate public
policies and interventions on more effective treatment
provision and future projections about requisite workforce
composition.
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